Comments
Bhopal, Apr 5 An India-Spain joint venture to manufacture, among other things, molecular biology enzymes/reagent widely used in the biotechnology field, was inaugurated here on Tuesday.
“3B Blackbio Biotech India Ltd” is a joint venture company of Kilpest India Ltd, a leading agrochemical company in central India, and two Spanish biotechnology companies.
It will also make molecular diagnostic kit based on Spanish patented technology for various diseases like Tuberculosis diagnostic,1st and 2nd line drug resistance tuberculosis, Malaria (Pf Vivax/Pf Falciparum), Dengue HPV, HBV and HCV, a Kilpest release said.
It will also provide early septicemia detection within 6 hours through universal bacterial & fungal identification kit and treatment for diabetes (risk prediction & drug metabolism).
The joint venture will help in research and development of new tools in the field of personalised medicines, medical diagnostic, pharmacogenomics as well as provide diagnostic tests to predict drug treatment effectiveness. It will also enter the field of nutrigenomics.
The plant was inaugurated by Madhya Pradesh Health minister Mr Narottam Mishra.
Mr Erik Rovina Mardones, commercial counsellor in the Embassy of Spain and Mr Adrian Gutierrez, chief representative CDTI (Spain’s national innovative agency, ministry of science and technology) were also present on the occasion.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.